These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 35450284)
21. Early events in herpes simplex virus lifecycle with implications for an infection of lifetime. Salameh S; Sheth U; Shukla D Open Virol J; 2012; 6():1-6. PubMed ID: 22291864 [TBL] [Abstract][Full Text] [Related]
22. Human herpesvirus 8 envelope-associated glycoprotein B interacts with heparan sulfate-like moieties. Akula SM; Pramod NP; Wang FZ; Chandran B Virology; 2001 Jun; 284(2):235-49. PubMed ID: 11384223 [TBL] [Abstract][Full Text] [Related]
23. Herpes simplex virus types 1 and 2 differ in their interaction with heparan sulfate. Trybala E; Liljeqvist JA; Svennerholm B; Bergström T J Virol; 2000 Oct; 74(19):9106-14. PubMed ID: 10982357 [TBL] [Abstract][Full Text] [Related]
24. Anticytomegalovirus Peptides Point to New Insights for CMV Entry Mechanisms and the Limitations of Jackson JW; Hancock TJ; Dogra P; Patel R; Arav-Boger R; Williams AD; Kennel SJ; Wall JS; Sparer TE mSphere; 2019 Feb; 4(1):. PubMed ID: 30760613 [TBL] [Abstract][Full Text] [Related]
25. Monoclonal Antibodies to Different Components of the Human Cytomegalovirus (HCMV) Pentamer gH/gL/pUL128L and Trimer gH/gL/gO as well as Antibodies Elicited during Primary HCMV Infection Prevent Epithelial Cell Syncytium Formation. Gerna G; Percivalle E; Perez L; Lanzavecchia A; Lilleri D J Virol; 2016 Jul; 90(14):6216-6223. PubMed ID: 27122579 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of Human Cytomegalovirus Entry into Host Cells Through a Pleiotropic Small Molecule. Elste J; Kaltenbach D; Patel VR; Nguyen MT; Sharthiya H; Tandon R; Mehta SK; Volin MV; Fornaro M; Tiwari V; Desai UR Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32121406 [TBL] [Abstract][Full Text] [Related]
27. A role for heparan sulfate 3-O-sulfotransferase isoform 2 in herpes simplex virus type 1 entry and spread. O'Donnell CD; Tiwari V; Oh MJ; Shukla D Virology; 2006 Mar; 346(2):452-9. PubMed ID: 16336986 [TBL] [Abstract][Full Text] [Related]
28. Cell Fusion Induced by a Fusion-Active Form of Human Cytomegalovirus Glycoprotein B (gB) Is Inhibited by Antibodies Directed at Antigenic Domain 5 in the Ectodomain of gB. Reuter N; Kropff B; Schneiderbanger JK; Alt M; Krawczyk A; Sinzger C; Winkler TH; Britt WJ; Mach M; Thomas M J Virol; 2020 Aug; 94(18):. PubMed ID: 32641474 [TBL] [Abstract][Full Text] [Related]
29. Diversity of heparan sulfate and HSV entry: basic understanding and treatment strategies. Tiwari V; Tarbutton MS; Shukla D Molecules; 2015 Feb; 20(2):2707-27. PubMed ID: 25665065 [TBL] [Abstract][Full Text] [Related]
30. Molecular analysis of the immune response to human cytomegalovirus glycoprotein B (gB). II. Low gB-specific T and B cell responses are associated with expression of certain HLA-DR alleles. Curtsinger JM; Liu YN; Radeke R; Bryon MK; Fuad S; Bach FH; Gehrz RC J Gen Virol; 1994 Feb; 75 ( Pt 2)():301-7. PubMed ID: 8113751 [TBL] [Abstract][Full Text] [Related]
31. The glycoprotein B disintegrin-like domain binds beta 1 integrin to mediate cytomegalovirus entry. Feire AL; Roy RM; Manley K; Compton T J Virol; 2010 Oct; 84(19):10026-37. PubMed ID: 20660204 [TBL] [Abstract][Full Text] [Related]
32. Intrahost Dynamics of Human Cytomegalovirus Variants Acquired by Seronegative Glycoprotein B Vaccinees. Nelson CS; Vera Cruz D; Su M; Xie G; Vandergrift N; Pass RF; Forman M; Diener-West M; Koelle K; Arav-Boger R; Permar SR J Virol; 2019 Mar; 93(5):. PubMed ID: 30518646 [TBL] [Abstract][Full Text] [Related]
33. Initiation of human cytomegalovirus infection requires initial interaction with cell surface heparan sulfate. Compton T; Nowlin DM; Cooper NR Virology; 1993 Apr; 193(2):834-41. PubMed ID: 8384757 [TBL] [Abstract][Full Text] [Related]
34. Entry of human cytomegalovirus into porcine endothelial cells depends on both the cellular vascular origin and the viral strain. Taveira A; Ponroy N; Mueller NJ; Millard AL Xenotransplantation; 2014; 21(4):324-40. PubMed ID: 24712388 [TBL] [Abstract][Full Text] [Related]
35. Herpes simplex virus type-1 (HSV-1) entry into human mesenchymal stem cells is heavily dependent on heparan sulfate. Choudhary S; Marquez M; Alencastro F; Spors F; Zhao Y; Tiwari V J Biomed Biotechnol; 2011; 2011():264350. PubMed ID: 21799659 [TBL] [Abstract][Full Text] [Related]
37. Proteolytic processing of human cytomegalovirus glycoprotein B is dispensable for viral growth in culture. Strive T; Borst E; Messerle M; Radsak K J Virol; 2002 Feb; 76(3):1252-64. PubMed ID: 11773401 [TBL] [Abstract][Full Text] [Related]
38. Peptide inhibition of human cytomegalovirus infection. Melnik LI; Garry RF; Morris CA Virol J; 2011 Feb; 8():76. PubMed ID: 21342525 [TBL] [Abstract][Full Text] [Related]
39. Human cytomegalovirus vaccine based on the envelope gH/gL pentamer complex. Wussow F; Chiuppesi F; Martinez J; Campo J; Johnson E; Flechsig C; Newell M; Tran E; Ortiz J; La Rosa C; Herrmann A; Longmate J; Chakraborty R; Barry PA; Diamond DJ PLoS Pathog; 2014 Nov; 10(11):e1004524. PubMed ID: 25412505 [TBL] [Abstract][Full Text] [Related]
40. Human cytomegalovirus glycoprotein B variants affect viral entry, cell fusion, and genome stability. Tang J; Frascaroli G; Lebbink RJ; Ostermann E; Brune W Proc Natl Acad Sci U S A; 2019 Sep; 116(36):18021-18030. PubMed ID: 31427511 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]